These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 34194398

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Cost effectiveness of GnRH antagonists in patients with prostate cancer and cardiovascular risk : Comparative analysis against Leuprorelin by the Number Needed to Treat].
    Anderson D, Lehmann J, Ecker T, Vosgerau S, Donatz V.
    Urologe A; 2017 Jul; 56(7):917-924. PubMed ID: 28405705
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gonadotropin-Releasing Hormone Antagonists in Prostate Cancer.
    Kittai AS, Blank J, Graff JN.
    Oncology (Williston Park); 2018 Dec 17; 32(12):599-602, 604-6. PubMed ID: 30632129
    [Abstract] [Full Text] [Related]

  • 12. [Cardiovascular risk patients under androgen deprivation therapy: Lower risk with GnRH antagonists compared to LHRH agonists?].
    Merseburger AS, Sedding D, Hüter K.
    Urologe A; 2016 Feb 17; 55(2):218-25. PubMed ID: 26637324
    [Abstract] [Full Text] [Related]

  • 13. The role of LHRH antagonists in the treatment of prostate cancer.
    Crawford ED, Hou AH.
    Oncology (Williston Park); 2009 Jun 17; 23(7):626-30. PubMed ID: 19626830
    [Abstract] [Full Text] [Related]

  • 14. Risk of disease flare with LHRH agonist therapy in men with prostate cancer: myth or fact?
    Vis AN, van der Sluis TM, Al-Itejawi HHM, van Moorselaar RJA, Meuleman EJH.
    Urol Oncol; 2015 Jan 17; 33(1):7-15. PubMed ID: 25159013
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Degarelix: a new approach for the treatment of prostate cancer.
    Persson BE, Kold Olesen T, Jensen JK.
    Neuroendocrinology; 2009 Jan 17; 90(3):235-44. PubMed ID: 19602868
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.